公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2016 | Birth order and risk of nasopharyngeal carcinoma in multiplex families from Taiwan | Liu Z; Coghill A.E; Pfeiffer R.M; Hsu W.-L; PEI-JEN LOU ; CHENG-PING WANG ; Yu K.J; Niwa S; Brotzman M; Ye W; Chen C.-J; Hildesheim A. | International Journal of Cancer | 0 | 0 | |
2009 | Cancer patterns in nasopharyngeal carcinoma multiplex families in Taiwan | Yu K.J.; Hsu W.-L.; CHUN-JU CHIANG ; Cheng Y.-J.; Pfeiffer R.M.; Diehl S.R.; Goldstein A.M.; Gravitt P.E.; Chen C.-J.; Hildesheim A. | International Journal of Cancer | 24 | 23 | |
2021 | Cancer patterns in nasopharyngeal carcinoma multiplex families over 15 years | Yu K.J.; Hsu W.-L.; CHUN-JU CHIANG ; TSENG-CHENG CHEN ; Liu Z.; PEI-JEN LOU ; Diehl S.; Goldstein A.M.; Chen C.-J.; CHENG-PING WANG ; Hildesheim A. | Cancer | 0 | 1 | |
2013 | Characterization of ELISA detection of broad-spectrum anti-Epstein-Barr virus antibodies associated with nasopharyngeal carcinoma | Chang C; Middeldorp J; Yu K.J; Juwana H; Hsu W.-L; PEI-JEN LOU ; CHENG-PING WANG ; Chen J.-Y; Liu M.-Y; Pfeiffer R.M; Chen C.-J; Hildesheim A. | Journal of Medical Virology | 13 | 10 | |
2020 | Cigarette smoking increases the risk of nasopharyngeal carcinoma through the elevated level of IgA antibody against Epstein-Barr virus capsid antigen: A mediation analysis | Hsu W.-L.; Chien Y.-C.; Huang Y.-T.; Yu K.J.; JENG-YUH KO ; Lin C.-Y.; Tsou Y.-A.; Leu Y.-S.; Liao L.-J.; Chang Y.-L.; Su J.-Y.; Liu Z.; CHENG-PING WANG ; Terng S.-D.; Hua C.-H.; Lee J.-C.; TSUNG-LIN YANG ; Kate Hsiao C.-H.; MING-SHIANG WU ; Tsai M.-H.; Liu M.-J.; PEI-JEN LOU ; Hildesheim A.; Chen C.-J.; the GEV-NPC Study Group | Cancer Medicine | 12 | 12 | |
2012 | Correlates of anti-EBV EBNA1 IgA positivity among unaffected relatives from nasopharyngeal carcinoma multiplex families | Chang C.M; Yu K.J; Hsu W.L; Major J.M; Chen J.Y; PEI-JEN LOU ; Liu M.Y; Diehl S.R; Goldstein A.M; Chen C.J; Hildesheim A. | British Journal of Cancer | 5 | 4 | |
2018 | Elevated antibodies against Epstein-Barr virus among individuals predicted to carry nasopharyngeal carcinoma susceptibility variants | Coghill A.E; Hsu W.-L; Yang Q; CHENG-PING WANG ; PEI-JEN LOU ; Yu K.J; Yu G; Diehl S.R; Chen C.-J; Goldstein A.M; Hildesheim A. | Journal of General Virology | 3 | 3 | |
2014 | Epstein-barr virus serology as a potential screening marker for nasopharyngeal carcinoma among high-risk individuals from multiplex families in Taiwan | Coghill A.E; Hsu W.-L; Pfeiffer R.M; Juwana H; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Chen J.-Y; Chen C.-J; Middeldorp J.M; Hildesheim A. | Cancer Epidemiology Biomarkers and Prevention | 54 | 45 | |
2018 | Evaluation of nasal and nasopharyngeal swab collection for the detection of Epstein-Barr virus in nasopharyngeal carcinoma | Coghill A.E; CHENG-PING WANG ; Verkuijilen S.A.W.M; Yu K.J; Hsu W.-L; Middeldorp J.M; Hildesheim A. | Journal of Medical Virology | 14 | 13 | |
2019 | Evaluation of rare and common variants from suspected familial or sporadic nasopharyngeal carcinoma (NPC) susceptibility genes in sporadic NPC | Liu Z.; Goldstein A.M.; Hsu W.-L.; Yu K.J.; Chien Y.-C.; JENG-YUH KO ; Jian J.J.-M.; Tsou Y.-A.; Leu Y.-S.; Liao L.-J.; Chang Y.-L.; CHENG-PING WANG ; Wu J.-S.; Hua C.-H.; Lee J.-C.; TSUNG-LIN YANG ; CHUHSING KATE HSIAO ; MING-SHIANG WU ; Tsai M.-H.; Huang K.-K.; Yu K.; Jones K.; Zhu B.; Yeager M.; Yu G.; PEI-JEN LOU ; Chen C.-J.; Hildesheim A.; for the GEV-NPC group | Cancer Epidemiology Biomarkers and Prevention | 4 | 4 | |
2011 | Familial tendency and risk of nasopharyngeal carcinoma in Taiwan: Effects of covariates on risk | Hsu W.-L.; Yu K.J.; Chien Y.-C.; CHUN-JU CHIANG ; Cheng Y.-J.; Chen J.-Y.; Liu M.-Y.; Chou S.-P.; You S.-L.; Hsu M.-M.; PEI-JEN LOU ; CHENG-PING WANG ; Hong J.-H.; Leu Y.-S.; Tsai M.-H.; Su M.-C.; Tsai S.-T.; Chao W.-Y.; Ger L.-P.; Chen P.-R.; Yang C.-S.; Hildesheim A.; Diehl S.R.; Chen C.-J. | American Journal of Epidemiology | 32 | 25 | |
2022 | Identifying Epstein-Barr virus peptide sequences associated with differential IgG antibody response | Coghill A.E.; Fang J.; Liu Z.; Chen C.-J.; Jarrett R.F.; Hjalgrim H.; Proietti C.; Yu K.J.; Hsu W.-L.; PEI-JEN LOU ; Wang C.-P.; Zhao Y.; Doolan D.L.; Hildesheim A. | International Journal of Infectious Diseases | 0 | 0 | |
2019 | Multilaboratory assessment of Epstein-Barr virus serologic assays: The case for standardization | Liu Z; Yu K.J; Coghill A.E; Brenner N; Cao S.-M; Chen C.-J; Chen Y; Doolan D.L; Hsu W.-L; Labo N; Middeldorp J.M; Miley W; Simon J; CHENG-PING WANG ; Waterboer T; Whitby D; Xie S.-H; Ye W; Hildesheim A. | Journal of Clinical Microbiology | 6 | 7 | |
2001 | Occupational exposure to wood, formaldehyde, and solvents and risk of nasopharyngeal carcinoma | Hildesheim A.; Dosemeci M.; CHANG-CHUAN CHAN ; Chen C.-J.; Cheng Y.-J.; Hsu M.-M.; Chen I.-H.; Mittl B.F.; Sun B.; Levine P.H.; Chen J.-Y.; Brinton L.A.; Yang C.-S. | Cancer Epidemiology Biomarkers and Prevention | 139 | 107 | |
2018 | Patterns of Interindividual Variability in the Antibody Repertoire Targeting Proteins Across the Epstein-Barr Virus Proteome | Liu Z; Coghill A.E; Pfeiffer R.M; Proietti C; Hsu W.-L; Chien Y.-C; Lekieffre L; Krause L; Yu K.J; PEI-JEN LOU ; CHENG-PING WANG ; Mulvenna J; Middeldorp J.M; Bethony J; Chen C.-J; Doolan D.L; Hildesheim A. | Journal of Infectious Diseases | 13 | 12 | |
2011 | Prognostic utility of anti-EBV antibody testing for defining NPC risk among individuals from high-risk NPC families | Yu K.J.; Hsu W.-L.; Pfeiffer R.M.; CHUN-JU CHIANG ; CHENG-PING WANG ; PEI-JEN LOU ; Cheng Y.-J.; Gravitt P.; Diehl S.R.; Goldstein A.M.; Chen C.-J.; Hildesheim A. | Clinical Cancer Research | 52 | 49 |